Marine-Derived Phosphoeleganin and Its Semisynthetic Derivative Decrease IL6 Levels and Improve Insulin Signaling in Human Hepatocellular Carcinoma Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25116039 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ayewa L Agognon und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, Federico II University of Naples and URT "Genomic of Diabetes" of Institute of Experimental Endocrinology and O…. Hauptthemen laut MEDLINE: Interleukin-6, Insulin, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Universities and Research.
Abstract (Originalsprache)
Marine natural products constitute a great source of potential new antidiabetic drugs. The aim of this study was to evaluate the role of phosphoeleganin (PE), a polyketide purified from the Mediterranean ascidian Sidnyum elegans, and its derivatives PE/2 and PE/3 on insulin sensitivity in human hepatocellular carcinoma (HepG2) cells. In our experiments, insulin stimulates the phosphorylation of its receptor (INSR) and AKT by 1.5- and 3.5-fold, respectively, whereas in the presence of PE, PE/2, and PE/3, the insulin induced INSR phosphorylation is increased by 2.1-, 2-, and 1.5-fold and AKT phosphorylation by 7.1-, 6.0-, and 5.1-fold, respectively. Interestingly, PE and PE/2 have an additive effect on insulin-mediated reduction of phosphoenolpyruvate carboxykinase (PEPCK) expression. Finally, PE and PE/2, but not PE/3, decrease interleukin 6 (IL6) secretion and expression before and after palmitic acid incubation, while in the presence of high glucose (HG), only PE reduces IL6. Levels of other cytokines are not significantly affected by PE and its derivates. All these data suggest that PE and its synthetic-derived compound, PE/2, significantly decrease IL6 and improve hepatic insulin signaling. As IL6 impairs insulin action, it could be hypothesized that PE and PE/2, by inhibiting IL6, may improve the hepatic insulin pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medicine, Federico II University of Naples and URT "Genomic of Diabetes" of Institute of Experimental Endocrinology and Oncology, National Council of Research (CNR), Via Pansini 5, 80131 Napl…
- Department of Pharmacy, University of Naples "Federico II", Via D. Montesano 49, 80131 Napoli, Italy.
- Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, 80131 Naples, Italy.
ORCID-Profile: Marcello Casertano, Serena Cabaro, Pietro Formisano, Marialuisa Menna, Concetta Imperatore, Francesco Oriente
Förderung
- Ministry of Education, Universities and Research
Zitieren
APA
Agognon, A. L., Casertano, M., Vito, A., Orso, S., Cabaro, S., Mormone, F., Morelli, C., Perruolo, G., Formisano, P., Menna, M., Imperatore, C., & Oriente, F. (2024). Marine-Derived Phosphoeleganin and Its Semisynthetic Derivative Decrease IL6 Levels and Improve Insulin Signaling in Human Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25116039
Vancouver
Agognon AL, Casertano M, Vito A, Orso S, Cabaro S, Mormone F, et al. Marine-Derived Phosphoeleganin and Its Semisynthetic Derivative Decrease IL6 Levels and Improve Insulin Signaling in Human Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25116039
BibTeX
@article{Agognon2024,
author = {Agognon, Ayewa L and Casertano, Marcello and Vito, Alessio and Orso, Sonia and Cabaro, Serena and Mormone, Federica and Morelli, Cristina and Perruolo, Giuseppe and Formisano, Pietro and Menna, Marialuisa and Imperatore, Concetta and Oriente, Francesco},
title = {Marine-Derived Phosphoeleganin and Its Semisynthetic Derivative Decrease IL6 Levels and Improve Insulin Signaling in Human Hepatocellular Carcinoma Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25116039}
}
EUVIMED